Asit C. Mehta Financial Services Ltd. Overview
| Field | Detail | Source |
|---|---|---|
| Legal name | Asit C. Mehta Financial Services Limited | BSE filings; Letter of Offer (LoF) Dec-2023 |
| Former names | Northern India Leasing Limited (1984); Nucleus Securities Limited (from 8 Jul 1993); Nucleus Netsoft and GIS (India) Limited (from 31 May 2006); current name from 11 Sep 2008 | LoF Dec-2023 |
| Founding / incorporation | Incorporated 25 January 1984 as a public limited company. Certificate issued by the RoC, Delhi & Haryana | LoF Dec-2023 |
| Group heritage | Asit C. Mehta began equity broking in 1983 as a proprietorship. The broking subsidiary was reconstituted as a company in December 1993 | CRISIL rationale Aug-2024 / Nov-2025 |
| Jurisdiction | India. Companies Act, 1956/2013. Registered office moved to Maharashtra (RoC Mumbai) effective 26 Jul 1995 | LoF Dec-2023 |
| CIN | L65900MH1984PLC091326 | BSE filings |
| Registered office / HQ | Pantomath Nucleus House, Saki Vihar Road, Andheri (East), Mumbai 400072, Maharashtra | BSE filings 2024–2026 |
| Exchange / ticker | BSE: 530723 / ASITCFIN. Equity listed on BSE since August 1998 (per Simply Wall St). Not listed on NSE | BSE; Simply Wall St |
| ISIN | INE041B01014. No CUSIP: the shares carry no US listing or ADR | LoF Dec-2023 |
| Face value | ₹10 per share | LoF Dec-2023 |
| Shares outstanding | 82,46,012 equity shares (post-Rights Issue, January 2024) | Board's Report FY2024; Shareholding pattern Mar-2026 |
| Fiscal year end | 31 March | Annual Reports |
| Statutory auditor | M/s Manek & Associates, Chartered Accountants (FRN 0126679W). Appointed 18 Nov 2023 to fill a casual vacancy after M/s MSKA & Associates resigned; re-appointed at the 40th AGM (30 Sep 2024) | Board's Reports FY2024, FY2025 |
| Internal auditor | M/s MAKK & Associates (FRN 117246W), FY2025 | Board's Report FY2025 |
| Secretarial auditor | M/s Hemanshu Kapadia & Associates, Practising Company Secretaries | Board's Report FY2025 |
| Registrar & Transfer Agent | MUFG Intime India Pvt. Ltd. (formerly Link Intime India), Vikhroli (West), Mumbai | Vogue/Dion Global company page |
| Employees | Not publicly disclosed (see note below) | Board's Report FY2025; LoF Dec-2023 |
| Market capitalisation | ≈ ₹86–89 Cr. ₹88.8 Cr at ₹108 (3 Sep 2026, Screener); ≈ ₹86 Cr at ₹104 (9 Sep 2026, Anand Rathi). | Screener; Anand Rathi |
| 52-week range | ₹164 high / ₹92 low | Screener (Sep-2026) |
| Website | www.acmfsl.com. Subsidiary's retail platform: Investmentz (investmentz.com) | BSE filings |
| Parent / controlling shareholder | Cliqtrade Stock Brokers Pvt. Ltd. holds 52.20% (Pantomath Group, promoted by Mahavir and Madhu Lunawat). ACMFSL became a subsidiary of Cliqtrade after the January 2024 Rights Issue | Board's Report FY2024; Shareholding Mar-2026 |
| Material subsidiary | Asit C. Mehta Investment Interrmediates Ltd. (ACMIIL), 94.58% | Board's Report FY2024; CRISIL Nov-2025 |
| Other subsidiary | Edgytal Fintech Investment Services Pvt. Ltd., 90.38% at 31 Mar 2024 | Board's Report FY2024 |
Note on employee count. A consolidated headcount is not disclosed in the sources reviewed. The FY2025 Board's Report states that the standalone headcount is below the threshold that requires an Internal Complaints Committee under the POSH Act; that threshold is 10 employees. The Letter of Offer discloses group attrition of 35% in FY2021, 28% in FY2022 and 18% (annualised) in FY2023, but not absolute headcount. A three-year headcount trend is therefore not publicly disclosed.
ACMFSL is a micro-cap Indian holding company. Its economic value lies almost entirely in its 94.58% subsidiary, ACMIIL, a four-decade-old Mumbai full-service stockbroker, depository participant, research house and portfolio manager built by Asit C. Mehta and Deena Mehta. At the standalone level, ACMFSL owns and leases its Andheri office building ("Pantomath Nucleus House") to group companies, earns small corporate-advisory fees, and holds the fintech subsidiary Edgytal.
Between 2022 and 2024, control passed from the Mehta family to the Pantomath Group of Mahavir and Madhu Lunawat. This happened through an open offer, share purchases and a ₹45.27 Cr rights issue. Since then the business has been repositioned as the broking, wealth and distribution arm of a mid-market investment-banking ecosystem.
The company is sub-scale, carries roughly ₹106 Cr of consolidated borrowings, and has reported consolidated losses in each of FY2023–FY2026. Its investment case rests on Pantomath synergies, deleveraging and promoter capital support.
What the company does
ACMFSL operates on two layers.
Holding-company (standalone) layer. The listed company's own operations are small. In the FY2025 Board's Report, management states three things:
-
the company has let out its office premises on a lease / leave-and-license basis to group companies;
-
it earned ₹115.36 lakh from investment activities in FY2025;
-
its standalone gross earnings rose to ₹667.56 lakh, from ₹547.09 lakh in FY2024.
The standalone entity also provides advisory and consultancy services on fund mobilisation, capital restructuring and corporate financial strategy to SME clients. Fee income from this line was ₹28.25 lakh in FY2023 and ₹25.92 lakh in FY2024 (Board's Reports FY2023, FY2024).
Following the NCLT-sanctioned merger of the wholly-owned Nucleus IT Enabled Services Ltd. (order dated 20 January 2023; appointed date 31 March 2021), the standalone company also carries a residual IT-enabled services line. This line recorded ₹10.44 lakh of revenue in Q2 FY2026 (standalone results, Q2 FY2026, per ScanX).
Operating-subsidiary layer. Asit C. Mehta Investment Interrmediates Ltd. (ACMIIL) generates the large majority of consolidated revenue. The FY2025 Board's Report describes it as:
-
a material subsidiary providing broking, research and analysis, and distribution of PMS, mutual funds and other financial products;
-
a corporate member of BSE and NSE;
-
a depository participant with CDSL.
ACMIIL holds SEBI registrations for stock broking, depository participation, portfolio management and research analysis (LoF Dec-2023). CRISIL's November 2025 rationale lists its activities as retail and institutional broking, research, portfolio management services, distribution and margin trade funding.
Business model and revenue model
| Revenue stream | Nature | Entity | Approximate significance | Source |
|---|---|---|---|---|
| Brokerage (cash, F&O, currency, commodity) | Transaction fees on client turnover; full-service plus a discount plan | ACMIIL | Dominant. Stock broking and allied services were ₹26.69 Cr in 9M FY2024 against consolidated revenue from operations of ₹31.52 Cr (≈85%) | Equitybulls / company release, Feb-2024 |
| Depository (DP) fees | Account maintenance and transaction charges; CDSL DP | ACMIIL | — | LoF Dec-2023 |
| Interest income (margin trade funding, client financing, deposits) | Spread income | ACMIIL | — | CRISIL Nov-2025 |
| PMS management / performance fees | AUM-linked; discretionary PMS (ACE strategies) | ACMIIL | PMS AUM ≈ ₹145–180 Cr in 2026 | PMS Bazaar Jun-2026; Business Today |
| Distribution commissions (MF, IPO, bonds, FDs, NPS, insurance, AIF) | Trail and upfront commissions | ACMIIL | MF distribution business sold May 2026 for ₹6.59 Cr | ScanX, May/Aug 2026 |
| Institutional equities and research | Brokerage on institutional flows; research | ACMIIL | Scaling after Pantomath link (20 institutions onboarded per FY2023 Board's Report) | Board's Report FY2023 |
| Arbitrage / proprietary (delta-hedged) | Trading income | ACMIIL | — | CRISIL Aug-2024 |
| Fintech platform services | B2B wealthtech platform, IT services | Edgytal | ₹283.20 lakh (FY2024); ₹3.66 lakh (FY2025) | Board's Reports FY2024, FY2025 |
| Rental / leave-and-license | Lease of Pantomath Nucleus House to group companies | ACMFSL standalone | Core of standalone revenue | Board's Report FY2025 |
| Corporate advisory | Fund-mobilisation / restructuring advisory to SMEs | ACMFSL standalone | ₹25.92 lakh (FY2024) | Board's Report FY2024 |
ACMFSL's consolidated revenue is overwhelmingly service / transaction-based. There is no product sales, subscription or licensing revenue of any significance.
Value-chain position, customers and end-markets
In the Indian capital-markets value chain, ACMIIL sits at the intermediary / distribution layer. It stands between investors and market infrastructure institutions (BSE, NSE, MCX, CDSL) and between investors and product manufacturers (AMCs, issuers, AIF managers).
ACMFSL's customer types are:
-
retail investors, including HNIs, served through the Investmentz app/web/CTCL platforms and an associate network across roughly 218 cities (LoF Dec-2023);
-
NRIs, through dedicated distribution products;
-
institutional clients for equity research and execution;
-
SME corporates for advisory;
-
B2B intermediaries (sub-brokers, MF agents, insurance and postal agents) recruited for the B2B network (Board's Report FY2023).
All end-markets are domestic Indian. The FY2025 Board's Report records no foreign-exchange earnings or outgo.
The company's own description
In the Rights Issue Letter of Offer (Dec-2023), the company describes itself as a technology-led integrated financial services organisation. It says it operates through ACMIIL and Edgytal across stock broking, portfolio management, wealth management and fintech, and that its purpose is to provide appropriate financial services to every Indian entity (paraphrased).
The FY2025 Board's Report describes ACMIIL as having helped over 2 lakh customers build wealth over 42 years, and highlights two flagship products: iBasket and PMS.
Independent characterisation
ACMFSL is best understood as a thinly capitalised listed shell around a legacy full-service retail broker, now controlled by an investment-banking group seeking a broking and distribution platform. Four features define it.
-
Scale. ACMIIL's market share of retail equity broking turnover was about 0.001% in FY2025. Its share of exchange-level active clients was 0.04% as of March 2025, with an active base of 23,000–24,000 clients (CRISIL, Nov-2025).
-
Cost structure. ACMIIL's net cost-to-income ratio was 100% in FY2025 and 101% in H1 FY2026 (CRISIL, Nov-2025). This reflects heavy investment in people and technology that revenue has not yet absorbed.
-
Balance sheet. Consolidated borrowings were ₹106.37 Cr at March 2026, against consolidated net worth of roughly ₹23 Cr (Screener). This makes interest cost the single largest drag on earnings.
-
Strategic dependency. Revenue growth since FY2024 has been tied to deal flow and capital from the Pantomath Group. CRISIL explicitly notes business flowing in from Pantomath's IPO-solutions and AIF businesses, and the promoters' commitment to provide capital as required.
Strategy
Stated strategic themes (paraphrased from company documents)
-
Integrated, technology-led financial services. Provide.
-
Wealth management build-out. Distribute high-end products (PMS, AIFs, MFs) to affluent clients (Board's Report FY2023).
-
NRI distribution. Pan-India senior hiring for NRI products (Board's Report FY2023).
-
B2B network expansion. Recruit sub-brokers, insurance, MF and postal agents through webinars (Board's Report FY2023).
-
Inorganic consolidation. Acquire smaller broking firms that want to exit because of compliance cost (Board's Report FY2023; Investor Presentation Jun-2022, citing industry consolidation pressure).
-
Institutional equities research. Build research coverage to raise institutional rankings and flows (Board's Report FY2023). The Q3 FY2024 release attributes institutional broad-basing to Pantomath's investment-banking strength.
-
Retail micro-investing. "Chhota Nivesh", iBaskets, NPS, SGBs, G-secs, corporate FDs and T-bills, all on one app (Board's Report FY2023).
-
Pantomath ecosystem synergy. At the time of the Cliqtrade acquisition, Pantomath described the deal as part of diversification across investment banking, wealth and fund management, institutional outreach and broking. This included merging its PMS with ACM (Private Banker International, Feb-2023).
Initiatives announced in the last 24 months (Oct 2024 – Oct 2026)
| Date | Initiative | Detail / targets | Status | Source |
|---|---|---|---|---|
| FY2025 | Capital infusion into ACMIIL | ₹10 Cr through optionally convertible cumulative redeemable preference shares | Completed; ACMIIL gearing 3.1x (Mar 2025) and 2.3x (Sep 2025) | CRISIL Nov-2025 |
| 13 Aug 2024 (approved in FY2025) | Variation of Rights Issue objects | ₹250 lakh redirected from the Omniscience Capital Advisors acquisition to business expansion, IP development, working capital and promotion | Approved by Board; shareholder approval sought | Board's Report FY2024 |
| 11 Dec 2024 | Governance alignment of the material subsidiary | Listed-company IDs placed on the ACMIIL board after fresh broker registration | Completed | BSE filing |
| 31 Jul 2025 | ₹50 Cr Rights Issue | Price, ratio and record date delegated to a Rights Issue Committee | Pending. No letter of offer or record date located as of Oct 2026 | BSE filing 31 Jul 2025 |
| 14 May 2026 | Divestment of the MF distribution business | Slump sale to Wealth Company Pvt. Ltd. for ₹659 lakh, to strengthen ACMIIL's financial position, reduce losses and focus on core operations | Completed (gain booked in Q1 FY2027) | BSE / Sharekhan; ScanX; Groww |
| 2 Sep 2026 | Related-party transaction framework | AGM resolutions for RPT limits of up to ₹55.5 Cr and ₹50 Cr | Placed before the 42nd AGM (24 Sep 2026) | Screener / BSE |
| Ongoing | Discount broking plan | Compete with discount brokers for new clients | Launched (date not disclosed) | CRISIL Aug-2024 |
ESG and sustainability commitments: none announced. BRSR and CSR are not applicable (Board's Report FY2025).
Cost programmes: no formal programme or target is announced. FY2026 operating expenses fell ₹13 Cr year on year (Screener).
Medium-term targets and guidance
The company does not publish financial guidance or medium-term targets. There have been no earnings calls since the 2022 investor presentations. The only externally articulated benchmarks are CRISIL's rating-sensitivity thresholds for ACMIIL:
Upgrade triggers: a cost-to-income ratio sustainably below 70% and a higher client broking market share.
Downgrade triggers: cost-to-income above 100% for two further quarters, or gearing above 5x on a steady-state basis.
Products & Services
Broking and execution (ACMIIL)
| Offering | Description / capabilities | Target customer | Launch / status | Pricing model | Source |
|---|---|---|---|---|---|
| Equity cash broking (BSE / NSE) | Delivery and intraday execution | Retail, HNI, NRI | Since 1983/1993 | Turnover-linked brokerage (full-service); discount plan also offered | LoF Dec-2023; CRISIL Nov-2025 |
| Equity derivatives (F&O) | Futures and options on exchanges | Active traders, HNIs | Ongoing | Brokerage plus pass-through charges | LoF Dec-2023 |
| Currency and interest-rate derivatives | Exchange-traded currency and IRD | Traders, hedgers | Ongoing | Brokerage | LoF Dec-2023 |
| Commodity derivatives | MCX registration referenced | Traders | Ongoing | Brokerage | LoF Dec-2023 (risk factor references MCX) |
| Discount broking plan | Low-tariff plan to compete with discount brokers | Price-sensitive retail | Launched before Aug-2024 (exact date not disclosed) | Flat / low fees (rates not disclosed) | CRISIL Aug-2024 |
| Margin trade funding | Leveraged funding of client positions | Active retail / HNI | Ongoing | Interest income | LoF Dec-2023; CRISIL Nov-2025 |
| IPO / OFS / Offer-to-Buy | Exchange-platform primary and secondary offerings | Retail | Ongoing | Distribution / brokerage | LoF Dec-2023 |
| Institutional equities | Research-backed execution for institutions | Domestic institutions | 20 institutions onboarded per FY2023 Board's Report | Institutional brokerage | Board's Report FY2023 |
| Arbitrage trading | Delta-hedged arbitrage book | Proprietary | Ongoing | Trading gains | CRISIL Aug-2024 |
Platforms
| Platform | Description | Status | Source |
|---|---|---|---|
| Investmentz (app, web, CTCL) | Single digital platform for trading, investment products, IPOs, bonds, NPS, SGBs and more | Flagship retail platform | LoF Dec-2023; Board's Report FY2023 |
| EasyTradez.com | Trade-execution platform | Operational (per Simply Wall St description) | Simply Wall St |
| "Chhota Nivesh" | Platform for retail investors investing small sums | Launched around FY2023 | Board's Report FY2023 |
| Edgytal fintech platform | B2B wealthtech platform supporting distribution of marketable securities | Revenue collapsed to ₹3.66 lakh in FY2025 | Board's Reports FY2024, FY2025 |
Advisory, portfolio management and research
| Strategy | Category | Launch date | AUM | Benchmark | 3-year annualised return vs benchmark | Source |
|---|---|---|---|---|---|---|
| Asit C Mehta – ACE Multicap | Flexi / total-cap value strategy | 23 Aug 2018 | ₹142.07 Cr | BSE 500 TRI | 26.28% vs 13.47% | Groww PMS page (2026) |
| Asit C Mehta – ACE Multi-asset Portfolio | Value strategy with regular payouts; 95% equity at last disclosure | 4 Oct 2018 | ₹17.97 Cr | NSE Multi Asset Index 2 | 25.15% vs 11.44% | Groww PMS page |
| Asit C Mehta – ACE Ten Trillion Opportunities | Mid/small-cap value (76% small-cap) | 29 Dec 2017 | ₹9.59 Cr | BSE 500 TRI | 28.66% | Groww PMS page |
| Asit C Mehta – ACE Blue-chip | Large-cap value | 29 Dec 2017 | ₹4.40 Cr | BSE 500 TRI | 18.88% | Groww PMS page |
iBasket is a professionally curated stock basket built with a "scientific investing" approach. Per the FY2025 Board's Report, its stated aims are capital safety, value identification, thematic growth and under-researched opportunities. It targets retail and HNI investors. The launch year and pricing are not disclosed.
PMS (discretionary) — ACE strategies. Fund manager: Prathmesh Agrawal, CA, previously VP (Investments) at ENAM Asset Management; Deepak Makwana is also listed as a portfolio manager. Common terms across strategies: minimum investment ₹50 lakh (SEBI minimum) and an exit load of 2%.
PMS performance figures are as presented by third-party aggregators and are not SEBI-verified. Groww's "date as of" for the 3-year returns was not displayed.
Total PMS AUM. PMS Bazaar reports ₹146.04 Cr as of 30 June 2026; Sharescart reports ₹145 Cr as of 1 June 2026 (rank #228); Business Today reports ₹180.02 Cr (date not stated). The discrepancy likely reflects different reference dates.
Other advisory and research services:
Research Analyst services: (SEBI RA registration): equity research for retail and institutional clients (LoF Dec-2023).
Wealth management services: distribution of high-end products including PMS, AIFs and MFs, launched around FY2023 (Board's Report FY2023).
IPO reviews: published on third-party platforms; for example, a review of Ardee Industries' August 2026 IPO (IPOPremium).
Distribution and savings products
| Offering | Status | Source |
|---|---|---|
| Mutual fund distribution | Sold through a slump sale to Wealth Company Pvt. Ltd. for ₹659 lakh, approved 14 May 2026 | BSE / Sharekhan; ScanX |
| Fixed income: company FDs, T-Bills, RBI bonds, G-Secs | Offered online | LoF Dec-2023; Board's Report FY2023 |
| Sovereign Gold Bonds, digital gold | Offered | LoF Dec-2023 |
| National Pension System (NPS) | Offered on Investmentz | Board's Report FY2023 |
| NRI distribution products | Senior staff recruited pan-India | Board's Report FY2023 |
| Insurance / postal agent network (B2B) | Agents being registered through webinars | Board's Report FY2023 |
Depository and custody
ACMIIL is a CDSL depository participant. It held about ₹4,000 Cr of client securities in depository and about ₹100 Cr in advisory services as of August 2023 (LoF Dec-2023). Pricing is standard DP fees and is not disclosed.
Standalone (ACMFSL) services
| Offering | Detail | Source |
|---|---|---|
| Infrastructure leasing | Lease / leave-and-license of Pantomath Nucleus House to group companies | Board's Report FY2025 |
| Corporate advisory | Fund mobilisation, restructuring and corporate financial strategy for SMEs | Screener key points citing AR FY2025; Board's Report FY2024 |
| Investment activities | ₹115.36 lakh of revenue in FY2025 | Board's Report FY2025 |
| IT-enabled services (legacy Nucleus ITES) | BPO, data de-duping, digital consulting (SEO, SMO, paid media, web development), recruitment and training. ₹10.44 lakh of revenue in Q2 FY2026 | Simply Wall St; ScanX |
Financial Narrative
Income statement (consolidated)
Sources: Screener consolidated P&L; Board's Reports FY2023–FY2025. FY2022 total income from the FY2023 Board's Report. FY2026 total income of ₹6,588.94 lakh and net loss of ₹160.11 lakh from ScanX (FY2026 audited results). EPS discrepancy: for FY2023 and FY2024 the company-reported EPS is computed on loss attributable to owners over weighted shares, while Screener's derivation differs. FY2026 EPS is per Screener; Kotak Neo reports Q4 FY2026 EPS of ₹1.39 versus Screener's ₹1.24.
Margins and growth
Revenue CAGR (FY2022–FY2026):
-
Screener sales: (61.23 / 41.37)^(1/4) − 1 ≈ 10.3%
-
Company total income: (65.89 / 41.54)^(1/4) − 1 ≈ 12.2%
-
Screener reports 3-year compounded sales growth of 22% and 5-year growth of 9%.
Quarterly trajectory (consolidated)
Source: Screener consolidated quarterly. Q1 FY2027 net profit is ₹485.13 lakh per ScanX. Univest reports ₹4.00 Cr and IndMoney ₹4.56 Cr for the same quarter; the differences likely reflect profit attributable to owners versus total, or pre/post-OCI measures. Q1 FY2027 "other income" in the Screener basis includes the gain on the MF-distribution slump sale. ScanX separately reports underlying other income falling to ₹41.23 lakh from ₹112.85 lakh.
Commentary. The income statement shows a business whose operating line has recovered but whose financing structure absorbs all of it.
FY2022: was the high-water mark. Strong retail participation produced ₹11.9 Cr of EBITDA, and a small profit survived ₹7.9 Cr of interest.
FY2023–FY2024: saw ACMIIL's costs rise sharply as the new promoters hired senior staff and invested in technology, wealth management, NRI distribution and institutional research (Board's Report FY2023; CRISIL Aug-2024). EBITDA collapsed to about ₹1.4–1.6 Cr while interest rose above ₹10 Cr, producing losses of ₹9–11 Cr.
FY2025: was the inflection. Total income grew 65% to ₹77.9 Cr, with Q4 FY2025 alone contributing ₹29.5 Cr of sales, presumably institutional and IPO-linked flows from the Pantomath ecosystem. EBITDA recovered to ₹9.4 Cr, but net income remained negative after ₹10 Cr of interest.
FY2026: revenue fell 15% as market activity cooled and SEBI's F&O framework bit. However, EBITDA rose to ₹10.4 Cr, helped by ₹4.66 Cr of other income and cost reductions (operating expenses fell ₹13 Cr), and the net loss narrowed to ₹1.6 Cr.
Q1 FY2027: profit of about ₹4.85 Cr is non-recurring, driven by the MF-distribution sale. Underlying operating profit was slightly negative.
The quarterly pattern alternates between profitable and loss-making quarters. This is consistent with lumpy institutional, IPO and advisory revenues layered on a fixed cost and interest base of roughly ₹13–14 Cr per quarter.
Balance sheet (consolidated)
Sources: Screener consolidated balance sheet. Book value per share for FY2022–FY2025 per Bajaj Broking; FY2026 computed as ₹22.98 Cr / 82.46 lakh shares (Screener shows ₹27.9). FY2023 negative equity excludes the subsequent rights issue.
Items not available on a five-year basis:
Cash & equivalents: are not separately disclosed in the five-year aggregator data. Simply Wall St reports ₹32.5 Cr of cash, ₹98.6 Cr of debt and ₹24.3 Cr of equity, apparently as of 30 September 2025. Broker cash typically includes client and margin bank balances, so this figure overstates free cash.
Debt split: - The Letter of Offer (FY2023) shows unsecured borrowings of ₹5,707.38 lakh (31 Mar 2023), ₹4,745.32 lakh (31 Mar 2022) and ₹3,511.57 lakh (31 Mar 2021). The FY2023 balance comprised 4% unsecured redeemable NCDs (₹2,006.56 lakh), director loans (₹1,072.56 lakh), inter-corporate deposits at 11–12% (₹2,612.32 lakh) and other items. All of these were repayable on demand.
-
Secured debt includes ACMIIL's bank overdrafts (₹31.3 Cr sanctioned from SBI and Bank of India, per CRISIL) and the 10.5% secured NCDs (₹777 lakh per the FY2024 Board's Report; the same text cites "717" debentures of ₹1 lakh each, an internal inconsistency).
-
A precise short-term / long-term split for FY2026 is not publicly available in the sources reviewed. Simply Wall St notes that short-term liabilities (≈ ₹110 Cr) exceeded short-term assets (₹83 Cr).
Working capital: Screener working-capital days: FY2022 93.5; FY2023 −52.3; FY2024 −40.4; FY2025 14.8; FY2026 −418.1. These are not meaningful for a broker because client payables and receivables dominate.
Cash flow (consolidated)
Sources: Screener consolidated cash flows. Capex is derived as CFO minus FCF. Company-reported FY2023 consolidated CFO was ₹-568.74 lakh and FY2022 ₹-208.82 lakh (LoF), which differ slightly from Screener.
Commentary. Operating cash flow was negative in FY2022–FY2025 and only marginally positive in FY2026, with no internally generated free cash flow over five years. MarketsMojo similarly flags four consecutive years of negative operating cash flow up to FY2025.
The deficit was funded externally:
-
promoter and director loans and inter-corporate deposits (FY2021–FY2023);
-
the ₹45.27 Cr rights issue (FY2024), of which ₹27.45 Cr was a conversion of Cliqtrade's loan and ₹10.30 Cr repaid promoter and ICD loans;
-
fresh borrowings in FY2025.
FY2026 marks the first year of net debt repayment (−₹21.7 Cr financing outflow), partly funded by ₹11.2 Cr of investing inflows from investment liquidation; the investment book fell from ₹17.2 Cr to ₹6.6 Cr.
Key ratios
Sources: computed from Screener data. FY2023 ROE and D/E are not meaningful because consolidated equity was negative; they are shown as 0 for charting only. Screener reports FY2026 ROE of −6.84% on average equity and a 3-year average ROE of −23.6%.
Ratios not computable or not disclosed:
Net debt / EBITDA: not computable reliably without year-end free cash. On gross debt, debt/EBITDA was 10.2x in FY2026 and 12.6x in FY2025.
Current ratio: not disclosed on a five-year basis. Per Simply Wall St, short-term assets of ₹83.0 Cr against short-term liabilities of ₹110 Cr imply about 0.75x, apparently at September 2025.
ROIC: not disclosed. ROCE serves as the proxy.
Interpretation. Leverage is the defining financial characteristic. Interest of ₹9.5–11.1 Cr a year has exceeded or roughly equalled EBITDA in every year since FY2023.
At the subsidiary level, CRISIL reports ACMIIL gearing of 5.8x (FY2024), 3.1x (FY2025) and 2.3x (September 2025). This improvement came after ACMFSL infused ₹10 Cr of preference capital, funded by the rights issue.
At the holding-company level, the standalone entity carries significant legacy debt (standalone finance cost was ₹669.48 lakh in FY2025) against modest rental income. The planned ₹50 Cr rights issue would be decisive for deleveraging, but no record date or letter of offer had been located as of October 2026.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Group Entities
| Entity | Relationship | Stake held by ACMFSL | Activities | Source |
|---|---|---|---|---|
Cliqtrade Stock Brokers Pvt. Ltd. | Holding company of ACMFSL (Pantomath Group) | n/a (holds 52.20% of ACMFSL) | Investment vehicle of Mahavir and Madhu Lunawat | Shareholding Mar-2026; CRISIL Nov-2025 |
Asit C. Mehta Financial Services Ltd. | Listed company (BSE) | — | Property leasing, SME advisory, investments, residual ITES | Board's Report FY2025 |
Asit C. Mehta Investment Interrmediates Ltd. (ACMIIL) | Material subsidiary | 94.58% (remainder held by Deena Mehta) | Broking, DP, PMS, research, distribution, MTF, institutional equities | Board's Report FY2024; CRISIL |
Edgytal Fintech Investment Services Pvt. Ltd. | Subsidiary | 90.38% (31 Mar 2024), up from 73% (Jun 2022) | Fintech platform for distribution of marketable securities | Board's Reports FY2024, FY2025 |
Nucleus IT Enabled Services Ltd. | Former wholly-owned subsidiary; merged into ACMFSL | Merged (appointed date 31 Mar 2021) | BPO / data de-duplication and digital consulting | Board's Report FY2023 |
Results by Segment
| Metric (INR Lakh) | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
ACMIIL income from operations (INR Lakh) | 3,569.26 | 2,750.99 | 4,051.54 | — |
ACMIIL total income per CRISIL (INR Lakh) | 3,967 | 3,164 | 4,493 | 7,610 |
Edgytal income from operations (INR Lakh) | 18.15 | 120.77 | 283.20 | 3.66 |
ACMFSL standalone revenue from operations (INR Lakh) | — | 335.22 | 461.77 | 416.05 |
ACMFSL standalone total income (INR Lakh) | 420.44 | 530.00 | 547.09 | 667.56 |
Consolidated revenue from operations (INR Lakh) | — | 2,920.67 | 4,239.88 | 7,264.08 |
Consolidated total income (INR Lakh) | 4,154.08 | 3,383.24 | 4,709.03 | 7,786.24 |
Results by Segment — ACMIIL PAT
| Metric (INR Lakh) | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
ACMIIL PAT (INR Lakh) | 626.09 | -255.43 | -533.76 | 15 |
Edgytal PAT (INR Lakh) | -23.46 | -129.23 | -28.45 | -1.92 |
ACMFSL standalone PAT (INR Lakh) | -438.70 | -559.99 | -502.28 | -281.73 |
Consolidated PAT (INR Lakh) | 146.33 | -931.25 | -1,111.33 | -276.30 |
Income Statement and Per-Share Data
| Metric (INR Cr) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Sales / revenue (Screener basis, INR Cr) | 41.37 | 33.74 | 46.26 | 77.08 | 61.23 |
Total income, company-reported (INR Cr) | 41.54 | 33.83 | 47.09 | 77.86 | 65.89 |
Operating expenses (INR Cr) | 30.35 | 32.44 | 45.45 | 68.49 | 55.45 |
Operating profit before other income (INR Cr) | 11.02 | 1.30 | 0.81 | 8.59 | 5.78 |
Other income (INR Cr) | 0.87 | 0.09 | 0.83 | 0.78 | 4.66 |
EBITDA (INR Cr) | 11.89 | 1.39 | 1.64 | 9.37 | 10.44 |
Depreciation (INR Cr) | 1.67 | 1.56 | 1.62 | 2.09 | 2.43 |
Operating income / EBIT (INR Cr) | 10.22 | -0.17 | 0.02 | 7.28 | 8.01 |
Finance cost (INR Cr) | 7.93 | 10.17 | 11.11 | 10.02 | 9.53 |
Profit before tax (INR Cr) | 2.29 | -10.34 | -11.09 | -2.74 | -1.52 |
Net profit (INR Cr) | 1.46 | -9.31 | -11.12 | -2.76 | -1.60 |
EPS basic, Screener (INR) | 1.32 | -10.88 | -13.10 | -3.35 | -2.01 |
EPS basic & diluted, company-reported (INR) | 3.02 | -19.06 | -19.51 | -3.35 | -2.01 |
Dividend per share (INR) | 0 | 0 | 0 | 0 | 0 |
Margin Analysis (%)
| Metric (%) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Operating margin before other income, Screener OPM (%) | 26.64 | 3.85 | 1.75 | 11.14 | 9.44 |
EBITDA margin on total income (%) | 28.6 | 4.1 | 3.5 | 12.0 | 15.8 |
EBIT margin on total income (%) | 24.6 | -0.5 | 0.0 | 9.4 | 12.2 |
Net margin on total income (%) | 3.5 | -27.5 | -23.6 | -3.5 | -2.4 |
Total income growth YoY (%) | — | -18.6 | 39.2 | 65.3 | -15.4 |
Income Statement
| Metric (INR Cr) | Q2FY2025 | Q3FY2025 | Q4FY2025 | Q1FY2026 | Q2FY2026 | Q3FY2026 | Q4FY2026 | Q1FY2027 |
|---|---|---|---|---|---|---|---|---|
Sales (INR Cr) | 14.81 | 15.34 | 29.53 | 11.24 | 21.67 | 13.58 | 14.73 | 11.24 |
Other income (INR Cr) | 1.55 | 1.32 | 1.12 | 1.54 | 1.27 | 1.04 | 0.80 | 7.74 |
Operating profit (INR Cr) | 1.06 | -0.88 | 4.50 | -0.95 | 3.34 | -0.03 | 3.44 | -0.02 |
Interest (INR Cr) | 2.56 | 2.50 | 2.80 | 2.44 | 2.47 | 2.35 | 2.28 | 2.04 |
Profit before tax (INR Cr) | -0.45 | -2.57 | 2.26 | -2.45 | 1.54 | -1.94 | 1.33 | 4.97 |
Net profit (INR Cr) | -0.33 | -2.53 | 2.01 | -2.41 | 1.57 | -1.92 | 1.15 | 4.85 |
Balance Sheet and Per-Share Data
| Metric (INR Cr) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Equity share capital (INR Cr) | 4.85 | 4.95 | 8.25 | 8.25 | 8.25 |
Reserves (INR Cr) | 1.01 | -8.39 | 20.93 | 17.29 | 14.73 |
Shareholders' equity (INR Cr) | 5.86 | -3.44 | 29.18 | 25.54 | 22.98 |
Borrowings, total (INR Cr) | 106.65 | 116.28 | 92.88 | 118.02 | 106.37 |
Other liabilities (INR Cr) | 57.83 | 46.45 | 70.01 | 54.47 | 60.41 |
Total assets (INR Cr) | 170.34 | 159.29 | 192.07 | 198.03 | 189.76 |
Fixed assets, net (INR Cr) | 56.81 | 55.47 | 57.34 | 58.29 | 58.48 |
Capital work-in-progress (INR Cr) | 10.00 | 11.20 | 12.22 | 10.28 | 8.19 |
Investments (INR Cr) | 7.37 | 10.34 | 9.20 | 17.16 | 6.60 |
Other assets incl. cash, receivables, client balances (INR Cr) | 96.16 | 82.28 | 113.31 | 112.30 | 116.49 |
Book value per share (INR) | 12.09 | -6.93 | 35.38 | 30.97 | 27.87 |
Cash Flow
| Metric (INR Cr) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Cash from operating activities (INR Cr) | -3.34 | -5.69 | -0.42 | -6.37 | 0.39 |
Capital expenditure, derived (INR Cr) | 11.26 | 1.47 | 4.58 | 1.09 | 0.64 |
Free cash flow (INR Cr) | -14.60 | -7.16 | -5.00 | -7.46 | -0.25 |
Cash from investing activities (INR Cr) | -22.77 | 3.59 | -12.08 | -0.44 | 11.21 |
Cash from financing activities (INR Cr) | 28.33 | 1.05 | 10.81 | 14.72 | -21.65 |
Net cash flow (INR Cr) | 2.22 | -1.05 | -1.69 | 7.90 | -10.05 |
Dividends paid (INR Cr) | 0 | 0 | 0 | 0 | 0 |
Share buybacks (INR Cr) | 0 | 0 | 0 | 0 | 0 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
ROE, year-end equity (%) | 24.9 | 0 | -38.1 | -10.8 | -7.0 |
ROA (%) | 0.86 | -5.84 | -5.79 | -1.39 | -0.84 |
ROCE, Screener (%) | 8.14 | -0.15 | 0.02 | 5.41 | 5.79 |
Debt / equity (x) | 18.2 | 0 | 3.18 | 4.62 | 4.63 |
Interest coverage, EBITDA / interest (x) | 1.50 | 0.14 | 0.15 | 0.94 | 1.10 |
Asset turnover, sales / total assets (x) | 0.24 | 0.21 | 0.24 | 0.39 | 0.32 |
Debtor days / cash conversion cycle (days) | 48.08 | 68.48 | 87.74 | 39.26 | 71.95 |
Results by Region
| Region (INR Cr) | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
India, total income (INR Cr) | 47.09 | 77.86 | 65.89 |
Outside India, total income (INR Cr) | 0 | 0 | 0 |
Valuation Snapshot
| Metric | Value | Date | Source |
|---|---|---|---|
Last verified price | ₹104.00 | 9 Sep 2026 | Anand Rathi |
Prior reference | ₹108 (−2.97% on day) | 3 Sep 2026 | Screener |
Market capitalisation | ≈ ₹86 Cr (₹104) to ₹88.8 Cr (₹108) | Sep 2026 | Computed; Screener |
52-week high / low | ₹164 / ₹92 | 2026 | Screener; Upstox |
Liquidity | Thin (e.g. 631 shares traded on 18 Jun 2026) | Jun 2026 | MarketsMojo |
CAGR by Horizon
| Horizon | CAGR (%) |
|---|---|
1-year | -17 |
3-year | -2 |
5-year | 8 |
10-year | 26 |
Valuation Multiples
| Multiple | ACMFSL | Basis / comment | Source |
|---|---|---|---|
P/E (TTM) | ≈ 15.7x on ₹5.65 Cr TTM PAT at ₹88.8 Cr market cap | TTM includes the one-off gain on the MF business sale; P/E is negative ex-gain | Computed from Screener |
P/B | ≈ 3.9x (₹108 / ₹27.9 book) | Range of 4.1–4.4x reported by ICICIdirect and Anand Rathi in Jun–Sep 2026 | Screener; ICICIdirect; Anand Rathi |
EV / Sales | ≈ 3.2x gross of cash: (₹88.8 Cr + ₹106.4 Cr borrowings) / ₹61.2 Cr TTM sales | Overstated because cash is excluded | Computed |
EV / EBITDA | ≈ 18–19x gross of cash: ₹195 Cr / ₹10.4 Cr FY2026 EBITDA | Overstated because cash is excluded | Computed |
Key Events
| Event | Date | Shares | Price | Amount | Source |
|---|---|---|---|---|---|
Rights Issue | Dec 2023 – Jan 2024 | 32,93,452 | ₹137.45 | ₹4,526.85 lakh | LoF; Board's Report FY2024 |
Proposed Rights Issue | Approved 31 Jul 2025 | TBD | TBD | Up to ₹5,000 lakh | BSE filing |
Margin Analysis (%) — Promoter holding
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Promoter holding (%) | 74.59 | 77.53 | 74.99 | 74.99 | 74.99 |
Public holding (%) | 24.92 | 22.47 | 25.02 | 25.02 | 25.02 |
Number of shareholders | 2,962 | 1,997 | 2,188 | 2,083 | 2,050 |
Issuer Details
| Issuer | Agency | Rating | Outlook | Date | Facilities |
|---|---|---|---|---|---|
ACMFSL (listed parent) | — | Not rated by Moody's, S&P, Fitch or Indian agencies (no rating found) | — | — | — |
ACMIIL (subsidiary) | CRISIL Ratings | BBB- (long term) / A3 (short term) | Stable | Reaffirmed 24 Nov 2025 (previously Aug 2024, May 2023, Mar 2022, Jan 2022) | ₹40 Cr bank facilities: SBI OD ₹30 Cr; Bank of India OD ₹1.3 Cr; proposed LT ₹1.7 Cr; proposed ST ₹7 Cr |
Analyst Conclusions
Management guidance and consensus
Management provides no quantitative guidance and there is no consensus. Qualitatively, the May 2026 disclosures frame the MF-business sale as a step to improve net worth, reduce losses and focus on core operations. The pending ₹50 Cr rights issue signals intent to recapitalise.
CRISIL's expectation is that ACMIIL's market position will improve with Pantomath synergies. It treats profitable scale-up as a monitorable rather than a base case.
Bull case
-
Deleveraging re-rating. A fully subscribed ₹50 Cr rights issue, likely anchored by Cliqtrade given its record of converting ₹27.45 Cr of loans in 2024, could cut gross borrowings from ₹106 Cr to about ₹56 Cr. That would save roughly ₹5 Cr of annual interest at 10.5–12% and make the FY2026 EBITDA of ₹10.4 Cr translate into a sustainable profit.
-
Ecosystem revenue leverage. FY2025 showed that Pantomath-linked flows can lift revenue 65% in a year (Q4 FY2025 sales of ₹29.5 Cr). A recovering SME/mid-market IPO cycle could repeat this on a leaner cost base, since FY2026 operating expenses were ₹13 Cr lower.
-
Hidden asset value. The owned Andheri HQ (about ₹58 Cr of fixed assets at book), a PMS franchise with ₹145–180 Cr AUM and strong aggregator-reported returns, and residual investments provide asset backing. The ₹6.59 Cr MF-business sale shows a willingness to crystallise value.
Bear case
-
Structural unprofitability. Four consecutive annual losses (FY2023–FY2026), negative free cash flow in each of the last five years and ACMIIL cost-to-income at or above 100% suggest the franchise does not earn its cost of capital. The Q1 FY2027 profit is one-off.
-
Leverage and liquidity fragility. With D/E at 4.6x, interest coverage around 1x and demand-repayable ICDs and unsecured loans, any market downturn or lender recall could force further dilutive raises. The September 2026 NCD maturity adds near-term pressure.
-
Minority-shareholder governance risk. The holding is at the 75% promoter cap, RPT limits exceed net worth, a divested business may have gone to an affiliate, there is a history of SEBI and exchange penalties and frequent KMP and auditor turnover. At a P/B of about 4x, the stock prices in a turnaround that has not materialised.
Catalysts and monitorables (next 12 months)
| Catalyst / monitorable | Why it matters | Timing |
|---|---|---|
| Rights issue terms (price, ratio, record date) and promoter subscription | Determines dilution and deleveraging | Pending since Jul 2025 |
| Repayment or refinancing of the 10.5% NCDs (₹7.77 Cr) | Near-term liquidity test | ~Sep 2026 (verify) |
| 42nd AGM outcomes, especially RPT approvals and counterparties | Governance read-through | Held 24 Sep 2026 (verify) |
| Q2 FY2027 results (ex-gain profitability) | Tests the core earnings run-rate after the MF sale | Nov 2026 |
| CRISIL surveillance of ACMIIL (cost-to-income < 100%; gearing < 5x) | Downgrade triggers | ~Nov 2026 |
| SEBI F&O and MII rule effects on retail volumes | Revenue sensitivity | Ongoing |
| PMS AUM trajectory | Quality-revenue growth | Quarterly |
| Pantomath IPO / AIF pipeline flowing to ACMIIL | Lumpy revenue upside | Ongoing |
Concluding analyst verdict
Asit C. Mehta Financial Services is not, economically, the four-decade broking brand its name evokes. It is a leveraged micro-cap holding company whose value depends on whether a new controlling shareholder can turn a sub-scale, cost-heavy full-service broker into a profitable distribution arm.
Since Pantomath took control, the evidence is mixed but directionally improving:
-
revenue more than doubled between FY2023 and FY2025;
-
the subsidiary's gearing more than halved;
-
consolidated losses narrowed from ₹11.1 Cr in FY2024 to ₹1.6 Cr in FY2026;
-
the group has begun pruning non-core lines.
Yet the core problem is unresolved. Roughly ₹10 Cr of annual interest on about ₹106 Cr of borrowings consumes essentially all of an EBITDA that is itself volatile and partly dependent on related-group flows. The company has not produced free cash flow in five years, has paid no dividend since 2010, and carries no institutional ownership or analyst coverage.
At about ₹86–89 Cr of market value and roughly four times book, the market is already capitalising a successful recapitalisation and synergy story. The single most important variable is the long-pending ₹50 Cr rights issue: its pricing, the extent of Cliqtrade's participation, and whether the proceeds retire debt rather than fund related-party activity. Its execution would convert a balance-sheet-constrained story into one tested on operating merit.
Until then, the investment profile is that of a special situation with high governance and liquidity risk. Minority investors are largely along for the controlling group's ride and face dilution, related-party and illiquidity risks that the current valuation does not appear to discount. Prudent monitoring should centre on:
-
ex-gain quarterly profitability from Q2 FY2027;
-
ACMIIL's cost-to-income ratio relative to CRISIL's 100% downgrade trigger;
-
debt maturities;
-
the terms and counterparties of approved related-party transactions.
Verdict: speculative turnaround, contingent on recapitalisation. Fundamentals do not yet support the prevailing price-to-book multiple.
-
Consolidated employee headcount and its three-year trend.
-
FY2025 and FY2026 Ind AS 108 segment revenue and results (primary PDFs inaccessible).
-
Detailed KMP remuneration breakdown (salary, bonus, stock).
-
Year-end cash and equivalents, and the short-/long-term debt split for FY2022–FY2026.
-
Goodwill and intangibles.
-
Industry market-size estimates from primary sources.
-
Outcomes of the 42nd AGM (24 Sep 2026), NCD repayment status (Sep 2026) and the October 2026 share price.
-
Related-party status of Wealth Company Pvt. Ltd. (buyer of the MF distribution business).
-
Contents of the SEBI adjudication order of 29 Sep 2015 against ACMFSL.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Designation | Since | Background | Compensation (latest available) | Source |
|---|---|---|---|---|---|
Ambareesh Bhaskar Baliga | Chairman; Non-Executive Independent Director; Chair of NRC | Director since 26 Dec 2022. Chair since 2024/25 (signed the Q3 FY2026 results as Chairman) | — | Sitting fees ≈ ₹2.5 lakh | Board's Reports FY2023, FY2025; ScanX Jan-2026; Simply Wall St |
Krishan Kumar Jalan (DIN 01767702) | Non-Executive Independent Director; Chair of Audit Committee | 29 Jun 2024 (5-year term); on ACMIIL board from 11 Dec 2024 | — | — | Board's Report FY2025; BSE 12 Dec 2024 |
Suresh Kumar Jain (DIN 05103064) | Non-Executive Independent Director | 23 May 2024 (5-year term); on ACMIIL board from 11 Dec 2024 | — | — | Board's Report FY2025 |
Yagnesh P. Parikh (DIN 09762673) | Non-Executive Independent Director | 9 Nov 2023 (5-year term) | — | — | Board's Report FY2024 |
Deena Asit Mehta (DIN 00168992) | Non-Executive Non-Independent Director (promoter); Chair of SRC | Board tenure ≈ 34.7 years per Simply Wall St. Also MD of ACMIIL | CA (associate member, ICAI); postgraduate in management (finance). Former BSE President; former CDSL director; India Board of CISI (per CRISIL and public profiles) | Sitting fees ≈ ₹1.5 lakh; holds 4.13% | CRISIL; Wikipedia; Simply Wall St; Shareholding Mar-2026 |
Madhu Lunawat (DIN 06670573) | Non-Executive Non-Independent Director (promoter group, Pantomath) | 26 Dec 2022 | Pantomath co-founder; earlier at Infosys and ASREC (India); CFO of Edelweiss ARC; launched The Wealth Company Mutual Fund | — | CRISIL Nov-2025; Board's Report FY2023 |
“—” = not publicly disclosed.
Directors' Remuneration
| Committee | Members | Source |
|---|---|---|
Audit | K.K. Jalan (Chair), A. Baliga, M. Lunawat, S.K. Jain | Board's Report FY2025 |
Nomination & Remuneration | A. Baliga (Chair), K.K. Jalan, D. Mehta, Y. Parikh | Board's Report FY2025 |
Stakeholders' Relationship | D. Mehta (Chair), K.K. Jalan, A. Baliga, M. Lunawat, S.K. Jain | Board's Report FY2025 |
Executive Leadership Team
| Name | Role | Tenure | Age | Compensation | Source |
|---|---|---|---|---|---|
Binoy Kantilal Dharod | Chief Financial Officer (from 5 Aug 2022); Manager under the Companies Act (from 8 Feb 2024, 5-year term) | ≈ 4 years as CFO | 38 (per Simply Wall St, 2025) | ≈ ₹15 lakh total (per Simply Wall St; FY2025 basis) | Board's Reports FY2024, FY2025; Simply Wall St |
Ankit Kumar Jain | Company Secretary & Compliance Officer | From 13 Jan 2026 | — | — | ScanX / BSE Jan-2026 |
“—” = not publicly disclosed.
Board & Management Changes
| Date | Change | Context | Source |
|---|---|---|---|
26 Dec 2022 | Madhu Lunawat and Ambareesh Baliga appointed | Pantomath entry after the open offer | Board's Report FY2023 |
22 Aug 2023 | Manohar Lal Vij ceases | Pre-rights-issue board reshuffle | Board's Report FY2024 |
9 Nov 2023 | R.K. Murthy and Kirit Vora cease; Yagnesh Parikh appointed | Vora sold 2,48,350 ACMIIL shares to ACMFSL (rights-issue object) | Board's Report FY2024; LoF |
18 Nov 2023 | Auditor change (MSKA resigns; Manek appointed) | Second auditor change in about 17 months | Board's Reports FY2023, FY2024 |
8 Feb 2024 | Binoy Dharod appointed Manager | Replaced Pankaj Parmar | Board's Report FY2024 |
May–Jul 2024 | S.K. Jain and K.K. Jalan join; P. Sanyal retires | Board refresh | Board's Report FY2025 |
29 Oct 2024 | Asit C. Mehta resigns as Chairman and Director | Completes founder hand-over to Pantomath | Board's Report FY2025 |
27 Nov 2025 / 13 Jan 2026 | CS changes (Pandey out, Jain in) | Third CS in about three years | BSE; ScanX |
Major Shareholders
| Holder | Category | Shares | % |
|---|---|---|---|
Cliqtrade Stock Brokers Pvt. Ltd. | Promoter (corporate) | 43,04,282 | 52.20 |
Asit Chimanlal Mehta | Promoter | 14,43,693 | 17.51 |
Deena Asit Mehta | Promoter | 3,40,783 | 4.13 |
Asit Chimanlal Mehta HUF | Promoter | 77,000 | 0.93 |
Jayesh T. Desai HUF | Promoter | 11,854 | 0.14 |
Others in promoter group (Gopa J. Desai, Rupa A. Shah) | Promoter | ≈ 5,660 (derived) | ≈ 0.07 |
Total promoter & promoter group (7 holders) | — | 61,83,272 | 74.98 |
Public (2,092 holders) | Public | 20,62,740 | 25.02 |
Competitive Landscape
Competitors by Segment
| Segment | Named competitors | Relative positioning vs ACMIIL |
|---|---|---|
Discount / digital retail broking | Zerodha (unlisted), Groww (Billionbrains Garage Ventures), Angel One, Upstox, Dhan | Dominant scale; ACMIIL's 0.04% active-client share (Mar 2025) is tiny by comparison (CRISIL) |
Bank-led broking | ICICI Securities, HDFC Securities, Kotak Securities, SBI Securities, Axis Securities | Captive bank distribution; CRISIL flags the regulatory shift favouring larger digital and bank-based brokers |
Large listed full-service / wealth | Motilal Oswal Financial Services, IIFL Capital Services, Anand Rathi Share & Stock Brokers, Nuvama Wealth, Geojit Financial Services | Broad product shelves and research depth |
Small / mid listed brokers (closest peers) | Share India Securities, Monarch Networth Capital, SMC Global Securities, Arihant Capital Markets, Inventure Growth & Securities, Choice International | Comparable heritage, but most are profitable and larger |
Traditional Mumbai full-service (unlisted) | Prabhudas Lilladher, Nirmal Bang, Sharekhan (now Mirae Asset Sharekhan) | Same client archetype (HNI, relationship-led) |
Institutional equities / ECM-linked | DAM Capital Advisors, Equirus, Pantomath (sister group) | ACMIIL's institutional desk is nascent (20 institutions onboarded per FY2023) |
PMS / boutique wealth | Omniscience Capital, ENAM-heritage boutiques, Marcellus, numerous small PMS | ACMIIL's PMS AUM of ₹145–180 Cr ranks around #228 among PMS providers (Sharescart) |
Peer Comparison FY2026
| Metric | ACMFSL (consolidated) | DAM Capital Advisors | Share India Securities |
|---|---|---|---|
Q1 FY2027 total income | ≈ ₹18.98 Cr (incl. one-off gain; Screener total income) | ₹30.0 Cr (−2.9% YoY) | — |
Q1 FY2027 PAT | ₹4.85 Cr (one-off driven) | ₹0.15 Cr (0.5% margin) | Company cites highest-ever quarterly net profit |
Business mix | Retail broking, PMS, distribution | Merchant banking ₹9.5 Cr; institutional broking ₹16.3 Cr | Algo / tech-driven broking; average daily turnover ₹90 Bn |
Net cash / leverage | Net debt (borrowings ₹106 Cr, Mar 2026) | Net cash ₹312 Cr (30 Jun 2026) | ROA 1.71% (Q1 FY2027) |



